Used in organic synthesis as an intermediate for pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of reactive bromo and ether functional groups. Commonly employed in the preparation of quinoline-based compounds with potential anticonvulsant, antidepressant, or antitumor activity. Also utilized in research settings for designing novel heterocyclic compounds in medicinal chemistry.